Brueggen, Germany

Ralf Hoffmann

USPTO Granted Patents = 14 

Average Co-Inventor Count = 3.3

ph-index = 2

Forward Citations = 32(Granted Patents)


Location History:

  • 4320 Hattingen 13, DE (1994)
  • Hattingen/Ruhr, DE (2000)
  • 12349 Berlin, DE (2002)
  • Brüggen, DE (2011)
  • Eindhoven, NL (2023)
  • Brueggen, DE (2012 - 2024)

Company Filing History:


Years Active: 1994-2025

Loading Chart...
14 patents (USPTO):Explore Patents

Title: Ralf Hoffmann: Innovator in Medical Data Evaluation

Introduction

Ralf Hoffmann is a notable inventor based in Brueggen, Germany. He has made significant contributions to the field of medical data evaluation, holding a total of 14 patents. His work primarily focuses on utilizing advanced algorithms to improve clinical decision-making processes.

Latest Patents

One of Hoffmann's latest patents is titled "Evaluating input data using a deep learning algorithm." This invention provides a method for evaluating a set of input data, which includes clinical and genomic data from subjects. The method involves obtaining raw data arranged into clusters and tuning a deep learning algorithm to analyze this data. The algorithm consists of an input layer, an output layer, and multiple hidden layers. By performing statistical clustering on the raw data, Hoffmann's method generates statistical clusters and derives medical markers from them. This process ultimately evaluates the input data to extract relevant medical insights.

Another significant patent is "Pre-surgical risk stratification based on PDE4D7 expression and pre-surgical clinical variables." This invention relates to a method for assessing the risk of prostate cancer in patients. It involves determining the gene expression profile for phosphodiesterase 4D variant 7 (PDE4D7) from biological samples. By calculating a pre-surgical prognostic risk score based on this expression and other clinical variables, the method aims to enhance treatment decisions for prostate cancer patients.

Career Highlights

Hoffmann has worked with prominent companies, including Koninklijke Philips Corporation N.V. His experience in these organizations has contributed to his expertise in medical data evaluation and algorithm development.

Collaborations

Some of his notable coworkers include Marcia Alves De Inda and Miles Douglas Houslay. Their collaboration has likely played a role in advancing Hoffmann's innovative projects.

Conclusion

Ralf Hoffmann is a distinguished inventor whose work in medical data evaluation has the potential to significantly impact clinical practices. His innovative patents demonstrate a commitment to improving patient outcomes through advanced technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…